Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Akari Therapeutics Plc ADR (AKTX) Insider Trading Activity
Healthcare • Biotechnology • 6 employees
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.
Total Value
$1,069,392.78
Total Shares
7,957,521,639
Average Trade Value
$53,469.64
Most Active Insider
Patel Samir Rashmikant
Total Activity: $510,218
Largest Single Transaction
$503,143
by Patel Samir Rashmikant on Dec 2, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
CFO
|
Jan 10, 2025 | 200 | $244 | 200 (+100.0%) | Grant | |
| Jan 10, 2025 | 11,439 | $13,956 | 35,860 (+31.9%) | Grant | ||
| Jan 9, 2025 | 8,000,000 | $4,800 | 32,216,000 (+24.8%) | Grant | ||
| Jan 3, 2025 | 208,000 | $125 | 5,249,511,500 (+0.0%) | Grant | ||
| Jan 3, 2025 | 1,720,000 | $1,032 | 71,720,000 (+2.4%) | Grant | ||
| Dec 27, 2024 | 400,000 | $200 | 5,249,303,500 (+0.0%) | Grant | ||
| Dec 27, 2024 | 40,000,000 | $20,000 | 70,000,000 (+57.1%) | Grant | ||
| Dec 26, 2024 | 3,200,000 | $1,600 | 5,248,903,500 (+0.1%) | Grant | ||
| Dec 26, 2024 | 30,000,000 | $15,000 | 30,000,000 (+100.0%) | Grant | ||
| Dec 24, 2024 | 7,500,000 | $3,750 | 5,245,703,500 (+0.1%) | Grant | ||
| Dec 23, 2024 | 2,000,000 | $1,000 | 24,216,000 (+8.3%) | Grant | ||
| Dec 23, 2024 | 1,400,000 | $700 | 5,238,203,500 (+0.0%) | Grant | ||
| Dec 20, 2024 | 1,400,000 | $700 | 5,236,803,500 (+0.0%) | Grant | ||
| Dec 2, 2024 | 419,286,000 | $503,143 | 5,235,403,500 (+8.0%) | Grant | ||
| Dec 2, 2024 | 419,286,000 | $503,143 | 4,077,124,600 (+10.3%) | Grant | ||
| Nov 14, 2024 | 1,404,622,000 | $0 | 4,816,117,500 (+29.2%) | Grant | ||
| Nov 14, 2024 | 1,404,622,000 | $0 | 4,816,117,500 (+29.2%) | Grant | ||
| Nov 14, 2024 | 1,404,622,000 | $0 | 4,816,117,500 (+29.2%) | Grant | ||
| Nov 14, 2024 | 1,404,622,000 | $0 | 4,816,117,500 (+29.2%) | Grant | ||
| Nov 14, 2024 | 1,404,622,000 | $0 | 4,816,117,500 (+29.2%) | Grant |